Demographic, clinical and epidemiological pattern of COVID-19 in Santiago de Cuba, October-December 2020

Authors

Keywords:

COVID-19, implicative statistical analysis, demographic, clinical and epidemiological patterns, Santiago de Cuba.

Abstract

Introduction: The COVID-19 epidemic has changed its characteristics as new strains appear.

Objective: To identify the demographic, clinical and epidemiological characteristics that make up the pattern of the COVID-19 epidemic in Santiago de Cuba.

Material and Methods: An analytical observational study was carried out using the 461 cases of COVID-19 in Santiago de Cuba province from October to December 2020 as the study population. Demographic, clinical and epidemiological variables were selected and the implicative statistical analysis was applied.

Results: Among the confirmed females, the category of traveler and ages between 41 and 60 years prevailed; among males, patients without a source of infection, between 19 and 40 years or 60 and more years, with fever as the main symptom, and without personal pathological antecedents were more prevalent. Asymptomatic patients predominated in children under one year of age. Those over the age of 19 were associated with travelers. In patients 19 to 40 years of age, the predominant symptom was fever; in patients aged 40 and under, those without comorbidities prevailed; and in the elderly, diabetes mellitus prevailed. Among the older adults, there were more cases with no known source of infection and male predominance. Confirmed health workers were mainly between 41 and 60 years old and asymptomatic. Confirmed travelers were mostly women over 19 years of age and asymptomatic.

Conclusions: There were changes in the behavior of the disease in the province with respect to the first wave, with displacement of the association patterns between sex and age groups.

Downloads

Download data is not yet available.

References

1. Sagaró-del-Campo NM, Zamora-Matamoros L, Valdés-García LE, Rodríguez-Valdés A, Bandera-Jiménez D, Texidor-Garzón MC. Aspectos demográficos, clínico-epidemiológicos y geoespaciales de la COVID-19 en Santiago de Cuba. Archivo Médico Camagüey. 2021[acceso: 10/05/2021];25(3):391-404. Disponible en: http://www.revistaamc.sld.cu/index.php/amc/article/view/7979

2. Sagaró del Campo NM, Zamora Matamoros L, Valdés García LE, Bergues Cabrales LE, Rodríguez Valdés A, Morandeira Padrón HM. La COVID-19 en Santiago de Cuba desde un análisis estadístico implicativo. Rev Cubana Salud Pública. 2020 [consultado 10 ene 2021]; 46(Supl. especial):e2578. Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/2578

3. González-Castro A, Cuenca Fito E, Fernández A, Escudero Acha P, Rodríguez Borregán J, Peñasco Y. Primera y segunda oleada de enfermedad por coronavirus-19: Un estudio comparativo en pacientes hospitalizados en una UCI de un hospital universitario de tercer nivel. Medicina Intensiva. 2021[consultado 10 ene 2021]. DOI: 10.1016/j.medin.2021.02.009 Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938862/

4. Fan G, Yang Z, Lin Q, Zhao S, Yang L, He D. Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions. Transbound Emerg Dis. 2021;68:213–215. https://doi.org/10.1111/tbed.13819

5. Sagaró Del Campo NM, Zamora Matamoros L. ¿Cómo aplicar el análisis estadístico implicativo en los estudios de causalidad en salud? Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2020[Consultado 10 Ene 2021];45(1). Disponible en: http://revzoilomarinello.sld.cu/index.php/ zmv/article/view/196

6. Sagaró Del Campo NM, Zamora Matamoros L. ¿Cómo interpretar el análisis en los estudios de causalidad en salud? MEDISUR. 2020[Consultado 10 Ene 2021];18(2). Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/4415

7. Sagaró Del Campo NM, Zamora Matamoros L. Métodos actuales para asegurar la validez de los estudios de causalidad en medicina. Gac. Méd. Espirit. 2019[Consultado 10 Ene 2021];21(2):146-160. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1608-89212019000200146 &lng=es.Epub 02-Ago-2019

8. León Álvarez JL, Calderón Martínez C, Gutiérrez Rojas AR. Análisis de mortalidad y comorbilidad por COVID-19 en Cuba. Revista Cubana de Medicina. 2021[Consultado 10 Ene 2021];60(2):e2117. Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/2117/2056

9. Chen, N, Zhou M, Dong X, Qu J, Gong F, Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020[Consultado 12 Feb 2021];395(10223):507–513. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620302117

10. Ruiz Cantero MT. Las estadísticas sanitarias y la invisibilidad por sexo y de género durante la epidemia de COVID-19. Gac Sanit. 2021[Consultado 12 Feb 2021];35(1):95–98. Disponible en: https://www.sciencedirect.com/science/article/pii/S0213911120300911

11. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Iwasaki A. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020[Consultado 12 Feb 2021];588(7837):315-320. Disponible en: https://www.nature.com/articles/s41586-020-2700-3?campaign_id=154&emc=edit_cb_20200826&instance_id=21644&nl=coronavirus-briefing&regi_id=24067855&segment_id=36983&te=1&user_id=1e332bb8fb8c62a2815d500399088126

12. Gebhard C., Regitz-Zagrosek V, Neuhauser HK., Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex Differ. 2020[Consultado 17 Feb 2021];11:1-13. Disponible en: https://link.springer.com/content/pdf/10.1186/s13293-020-00304-9.pdf

13. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci. 2020 May 14[Consultado 12 Feb 2021];21(10):3474. doi: 10.3390/ijms21103474. Disponible en: https://www.mdpi.com/1422-0067/21/10/3474

14. Vega Rivero Jesús Alberto, Ruvalcaba Ledezma Jesús Carlos, Hernández Pacheco Iván, Acuña Gurrola María del Refugio, López Pontigo Lydia. La salud de las personas adultas mayores durante la pandemia de COVID-19. JONNPR. 2020[Consultado 2021 Jul 08]; 5(7):726-739. doi: 10.19230/jonnpr.3772. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2529-850X2020000700007&lng=es. Epub 05-Jul-2021.

15. Zamora-Matamoros L, Sagaró-del-Campo NM, Valdés-García LE, Benítez Jiménez I. Indicadores demográficos en la incidencia de la covid-19 en Santiago de Cuba. R. Bras. Est. Pop. 2021[Consultado 2021 Jul 08];38(1-17):e0153. Disponible en: http://dx.doi.org/10.20947/S0102-3098a0153

16. IRIS PAHO. Cuba frente a la covid-19. Boletín de la OPS/OMS en Cuba. mayo-junio2020[Consultado 2021 Mar 23];2(2042). Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52514/v24n2.pdf.pdf?sequence=1&isAllowed=y

17. Da Silveira Moreira R. Análises de classes latentes dos sintomas relacionados à COVID-19 no Brasil: resultados da PNAD-COVID19. Cadernos de Saúde Pública. 2021[citado 2021 Jul 08];37(1). doi: 10.1590/0102-311X00238420 Disponible en: https://www.scielo.br/j/csp/a/WSxLPSVrxdqDQ4FGkqTrS7C/?format=html&lang=pt

18. Hussin A, Rothan, Siddappa N, Byrareddy. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity. 2020[citado 2021 Feb 16];109(102433). Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0896841120300469

19. Palacio Cruz M, Santos E, Velázquez Cervantes MA, León Juarez M. COVID-19, una emergencia de salud pública mundial. Rev Clin Esp. 2020[Consultado 2021 Mar 23];221(1):55-61. doi: 10.1016/j.rce.2020.03.001 Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0014256520300928

20. Venero Fernández SJ, Gómez MM, Luna LC, de Armas Águila Y, Medina RS., Pérez Gónzalez DR, et al. Características epidemiológicas de la COVID-19 en La Habana, epicentro de Cuba. Revista Cubana de Higiene y Epidemiología. 2021 [Consultado 2021 Mar 23];58. Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/1025

21. Wang X, Jiang X, Huang Q, Wang H, Gurarie D, Ndeffo-Mbah M, et al. Risk factors of SARS-CoV-2 infection in healthcare workers: a retrospective study of a nosocomial outbreak. Sleep Medicine: X. 2020 [Consultado 2021 Mar 23];2:100028. Doi: 10.1016/j.sleepx.2020.100028. Disponible en: https://www.sciencedirect.com/science/article/pii/S2590142720300173?via%3Dihub

Published

2023-04-04

How to Cite

1.
Sagaró Del Campo NM, Zamora Matamoros L, Valdés García LE. Demographic, clinical and epidemiological pattern of COVID-19 in Santiago de Cuba, October-December 2020. Rev haban cienc méd [Internet]. 2023 Apr. 4 [cited 2025 Jul. 7];21(6):e4472. Available from: https://revhabanera.sld.cu/index.php/rhab/article/view/4472

Issue

Section

Epidemiological and Salubrity Sciences